Terminal agitation and delirium in patients with cancer.
Publication
, Journal Article
Schlögl, M; Jones, CA; Riese, F
Published in: Lancet Oncol
September 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
September 2020
Volume
21
Issue
9
Start / End Page
e410
Location
England
Related Subject Headings
- Terminal Care
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Goals
- Delirium
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Schlögl, M., Jones, C. A., & Riese, F. (2020). Terminal agitation and delirium in patients with cancer. Lancet Oncol, 21(9), e410. https://doi.org/10.1016/S1470-2045(20)30439-3
Schlögl, Mathias, Christopher A. Jones, and Florian Riese. “Terminal agitation and delirium in patients with cancer.” Lancet Oncol 21, no. 9 (September 2020): e410. https://doi.org/10.1016/S1470-2045(20)30439-3.
Schlögl M, Jones CA, Riese F. Terminal agitation and delirium in patients with cancer. Lancet Oncol. 2020 Sep;21(9):e410.
Schlögl, Mathias, et al. “Terminal agitation and delirium in patients with cancer.” Lancet Oncol, vol. 21, no. 9, Sept. 2020, p. e410. Pubmed, doi:10.1016/S1470-2045(20)30439-3.
Schlögl M, Jones CA, Riese F. Terminal agitation and delirium in patients with cancer. Lancet Oncol. 2020 Sep;21(9):e410.
Published In
Lancet Oncol
DOI
EISSN
1474-5488
Publication Date
September 2020
Volume
21
Issue
9
Start / End Page
e410
Location
England
Related Subject Headings
- Terminal Care
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Goals
- Delirium
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis